Molecular cloning, pharmacological characterization, and histochemical distribution of frog vasotocin and mesotocin receptors

Journal of Molecular Endocrinology

Volumn 33, Issue 1, 2004, Pages 293-313

  Acharjee, S ^b   Do Rego, J L ^a   Oh, D Y ^b   Moon, J S ^b   Ahn, R S ^b   Lee, K ^b   Bai, D G ^b   Vaudry, H ^a   Kwon, H B ^b   Seong, J Y ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGIPRESSIN; ARGIPRESTOCIN; ARGIPRESTOCIN RECEPTOR; COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; MESOTOCIN; MESOTOCIN RECEPTOR; MESSENGER RNA; OXYTOCIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

AMPHIBIA; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DIENCEPHALON; FEMALE; FROG; GENETIC TRANSCRIPTION; HISTOCHEMISTRY; HYPOPHYSIS; HYPOPHYSIS INTERMEDIATE LOBE; LIGAND BINDING; MALE; MESENCEPHALON; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TELENCEPHALON;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GTP-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION; LIGANDS; MALE; MOLECULAR SEQUENCE DATA; PITUITARY GLAND; RANA ESCULENTA; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 4444234702     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0330293     Document Type: Article

References (57)

1. Acher R, Chauvet J & Chauvet MT 1995 Man and the chimaera. Selective versus neutral oxytocin evolution. Advances in Experimental Medicine and Biology 395 615-627.
2. Akhundova A, Getmanova E, Gorbulev V, Carnazi E, Eggena P & Fahrenholz F 1996 Cloning and functional characterization of the amphibian mesotocin receptor, a member of the oxytocin/vasopressin receptor superfamily. European Journal of Biochemistry 237 759-767.
3. Alescio-Lautier B & Soumireu-Mourat B 1998 Role of vasopressin in learning and memory in the hippocampus. Progress in Brain Research 119 501-502.
4. Alexandre D, Anouar Y, Jegou S, Fournier A & Vaudry H 1999 A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Endocrinology 140 1285-1293.
5. Arora KK, Cheng Z & Catt KJ 1997 Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Molecular Endocrinology 11 1203-1212.
6. Barberis C, Mouillac B & and Durroux T 1998 Structural bases of vasopressin/oxytocin receptor function. Journal of Endocrinology 156 223-229.
7. Bockaert J & Pin JP 1999 Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO Journal 18 1723-1729.
8. Boyd SK 1997 Brain vasotocin pathways and the control of sexual behaviors in the bullfrog. Brain Research Bulletin 44 345-350.
9. Boyd SK, Tyler CJ & De Vries GJ 1992 Sexual dimorphism in the vasotocin system of the bullfrog (Rana catesbeiana). Journal of Comparative Neurology 325 313-325.
10. Breton C, Chellil H, Kabbaj-Benmansour M, Carnazzi E, Seyer R, Phalipou S, Morin D, Durroux T, Zingg H, Barberis C & Mouillac B 2001 Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor. Journal of Biological Chemistry 276 26931-26941.
11. Burbach JPH, Adan RAH, Lolait SJ, van Leeuwen FW, Mezey E, Palkovits M & Barberis C 1995 Molecular neurobiology and pharmacology of vasopressin/oxytocin receptor family. Cellular and Molecular Neurobiology 15 573-595.
12. Chibbar R, Miller FD & Mitchell BF 1993 Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. Journal of Clinical Investigation 91 185-192.
13. Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S & Barberis C 1995 Tyrl 15 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO Journal 14 2176-2182.
14. Cotte N, Balestre MN, Aumelas A, Mahe E, Phalipou S, Morin D, Hibert M, Manning M, Durroux T, Barberis C & Mouillac B 2000 Conserved aromatic residues in the transmembrane region VI of the Via vasopressin receptor differentiate agonist vs. antagonist ligand binding. European Journal of Biochemistry 267 4253-4263.
15. De Rouffignac C, Di Stefano A, Wittner M, Roinel N & Elalouf JM 1991 Consequences of differential effects of ADH and other peptide hormones on thick ascending limb of mammalian kidney. American Journal of Physiology 260 R1023-R1035.
16. Dierickx K & Vandesande F 1976 Immuno-enzyme cytochemical demonstration of mesotocinergic nerve fibers in the pars intermedia of the amphibian hypophysis. Cell and Tissue Research 174 25-53.
17. Fuxe K & Agnati LF 1991 Volume transmission in the brain. Novel mechanisms for neuronal transmission. In Advances in Neurosciences, pp 1-9. Eds K Fuxe & LF Agnati New York: Raven Press.
18. Gether U & Kobilka BK 1998 G protein-coupled receptors. II. Mechanism of agonist activation. Journal of Biological Chemistry 273 17979-17982.
19. Gimpl G & Fahrenholz F 2001 The oxytocin receptor system: structure, function, and regulation. Physiological Reviews 81 629-683.
20. González A & Smeets WJAJ 1992 Comparative analysis of the vasotocinergic and mesotocinergic cells and fibers in the brain of two amphibians, the anuran Rana ridibunda and the urodele Pleurodeles waltlii. Journal of Comparative Neurology 315 53-73.
21. González A, Marin O, Tuinhof R & Smeets WJ 1994 Ontogeny of catecholamine systems in the central nervous system of anuran amphibians: an immunohistochemical study with antibodies against tyrosine hydroxylase and dopamine. Journal of Comparative Neurology 346 63-79.
22. Hausmann H, Richters A, Kreienkamp HJ, Meyerhof W, Mattes H, Lederis K, Zwiers H & Richter D 1996 Mutational analysis and molecular modeling of the nonapeptide hormone binding domains of the [Arg8]vasotocin receptor. PNAS 93 6907-6912.
23. Ivell R, Balvers M, Rust W, Bathgate R & Einspanier A 1997 Oxytocin and male reproductive function. Advances in Experimental Medicine and Biology 424 253-264.
24. de Keyzer Y, Lenne F, Auzan C, Jegou S, Rene P, Vaudry H, Kuhn JM, Luton JP, Clauser E & Bertagna X 1996 The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. Journal of Clinical investigation 97 1311-1318.
25. Kimura T, Tanizawa O, Mori K, Brownstein MJ & Okayama H 1992 Structure and expression of a human oxytocin receptor. Nature 356 526-529.
26. Kohno S, Kamishima Y & Iguchi T 2003 Molecular cloning of an anuran V(2) type [Arg(8)] vasotocin receptor and mesotocin receptor: functional characterization and tissue expression in the Japanese tree frog (Hyla japonica). General and Comparative Endocrinology 132 485-498.
27. Lamacz M, Hindelang C, Tonon MC, Vaudry H & Stoeckel ME 1989 Three distinct thyrotropin-releasing hormone-immunoreactive axonal systems project in the median eminence-pituitary complex of the frog Rana ridibunda. Immunocytochemical evidence for co-localization of thyrotropin-releasing hormone and mesotocin in fibers innervating pars intermedia cells. Neuroscience 32 451-462.
28. Larcher A, Delarue C, Idres S, Lefebvre H, Feuilloley M, Vandesande F, Pelletier G & Vaudry H 1989 Identification of VT-like immunoreactivity in chromaffin cells of the frog adrenal gland: effect of VT on corticosteroid secretion. Endocrinology 125 2691-2700.
29. Larcher A, Delarue C, Homo-Delarche F, Kikuyama S, Kupryszewski G & Vaudry H 1992a Pharmacological characterization of VT stimulation of phosphoinositide turnover in frog adrenal gland. Endocrinology 130 475-483.
30. Larcher A, Lamacz M, Delarue C & Vaudry H 1992b Effect of vasotocin on cytosolic free calcium concentrations in frog adrenocortical cells in primary culture. Endocrinology 131 1087-1093.
31. Liu J & Wess J 1996 Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. Journal of Biological Chemistry 271 8772-8778.
32. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A & Brownstein MJ 1992 Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357 336-339.
33. MacMillan MA, Mark MA & Duan AW 1998 The release of β-endorphin and the neuropeptide-receptor mismatch in the brain. Brain Research 794 127-136.
34. Mahlmann S, Meyerhof W, Hausmann H, Heierhorst J, Schonrock C, Zwiers H, Lederis K & Richter D 1994 Structure, function, and phylogeny of [Arg8]VT receptors from teleost fish and toad. PNAS 91 1342-1345.
35. Mitchell R, McCulloch D, Lutz E, Johnson M, MacKenzie C, Fennell M, Fink G, Zhou W & Sealfon SC 1998 Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392 411-414.
36. Moore FL 1992 Evolutionary precedents for behavioral actions of oxytocin and vasopressin. Annals of the New Fork Academy of Sciences 652 156-165.
37. Moore FL, Richardson C & Lowry CA 2000 Sexual dimorphism in numbers of vasotocin-immunoreactive neurons in brain areas associated with reproductive behaviors in the roughskin newt. General and Comparative Endocrinology 117 281-298.
38. Morel A, O'Carroll AM, Brownstein MJ & Lolait SJ 1992 Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 356 523-526.
39. Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S & Barberis C 1995 The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. Journal of Biological Chemistry 270 25771-25777.
40. Neary TJ & Northcutt RG 1983 Nuclear organization of the bullfrog diencephalon. Journal of Comparative Neurology 213 262-278.
41. Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR & Matzuk MM 1996 Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. PNAS 93 11699-11704.
42. Northcutt RG & Kicliter E 1980 Organization of the amphibian telencephalon. In Comparative Neurology of the Telencephalon, pp 203-255. Ed. SOE Ebbeson. New York: Plenum Press.
43. Oh da Y, Wang L, Ahn RS, Park JY, Seong JY & Kwon HB 2003 Differential G protein coupling preference of mammalian and nonmammalian gonadotropin-releasing hormone receptors. Molecular and Cellular Endocrinology 205 89-98.
44. Pang PK & Sawyer WH 1978 Renal and vascular responses of the bullfrog (Rana catesbeiana) to mesotocin. American Journal of Physiology 235 F151-F155.
45. Pedersen CA & Prange AJ Jr 1979 Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. PNAS 76 6661-6665.
46. Rose JD & Moore FL 2002 Behavioral neuroendocrinology of vasotocin and vasopressin and the sensorimotor processing hypothesis. Frontiers in Neuroendocrinology 23 317-341.
47. Seong JY, Wang L, Oh DY, Yun O, Maiti K, Li JH, Soh JM, Choi HS, Kim K, Vaudry H & Kwon HB 2003 Ala/Thr(201) in extracellular loop 2 and Leu/Phe(290) in transmembrane domain 6 of type 1 frog gonadotropin-releasing hormone receptor confer differential ligand sensitivity and signal transduction. Endocrinology 144 454-466.
48. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S & Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. Journal of Biological Chemistry 269 27088-27092.
49. Szczepanska-Sadowska E 1996 Interaction of vasopressin and angiotensin II in central control of blood pressure and thirst. Regulatory Peptides 66 65-71.
50. Tan FL, Lolait SJ, Brownstein MJ, Saito N, MacLeod V, Baeyens DA, Mayeux PR, Jones SM & Cornett LE 2000 Molecular cloning and functional characterization of a VT receptor subtype that is expressed in the shell gland and brain of the domestic chicken. Biology of Reproduction 62 8-15.
51. Tonon MC, Burlet A, Lauber M, Cuet P, Jegou S, Gouteux L, Ling N & Vaudry H 1985 Immunohistochemical localization and radioimmunoassay of corticotropin-releasing factor in the forebrain and hypophysis of the frog Rana ridibunda. Neuroendocrinology 40 109-119.
52. Tonon MC, Cuet P, Lamacz M, Jegou S, Cote J, Gouteux L, Ling N, Pelletier G & Vaudry H 1986 Comparative effects of corticotropin-releasing factor, arginine vasopressin, and related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior pituitary cells and neurointermediate lobes in vitro. General and Comparative Endocrinology 61 438-445.
53. Ufer E, Postina R, Gorbulev V & Fahrenholz F 1995 An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Letters 362 19-23.
54. Warburg MR 1995 Hormonal effect on the osmotic, electrolyte and nitrogen balance in terrestrial amphibia. Zoological Science 12 1-11.
55. Warne JM 2001 Cloning and characterization of an arginine VT receptor from the euryhaline flounder Platichthys flesus. General and Comparative Endocrinology 122 312-319.
56. de Wied D, Diamant M & Fodor M 1993 Central nervous system effects of the neurohypophyseal hormones and related peptides. Frontiers in Neuroendocrinology 14 251-302.
57. Zhu X, Gilbert S, Birnbaumer M & Birnbaumer L 1994 Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Molecular Pharmacology 46 460-469.